Proteomics Market worth $55.9 billion Global Update, Share Analysis, Leading Players, Business Opportunities, Forecast by 2026

December 14 21:00 2022
Proteomics Market worth $55.9 billion Global Update, Share Analysis, Leading Players, Business Opportunities, Forecast by 2026
Clinical Diagnostics segment to register the largest share during the forecast period
Browse 161 market data Tables and 47 Figures spread through 296 Pages and in-depth TOC on “Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) – Global Forecast to 2026

Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) – Global Forecast to 2026 according to a new report by MarketsandMarkets. The global Proteomics Market is valued at an estimated USD 25.9 billion in 2021 and is projected to reach USD 55.9 billion by 2026, at a CAGR of 16.6%. An increase in the research activity, especially in the area of personalized medicine and drug discovery, is the primary growth driver for this market. In addition, the increasing R&D expenditure by pharmaceutical and biotechnology companies, increasing government funding, and technological advancements are also propelling the market growth.

 Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731

 Browse in-depth TOC on “Proteomics Market”

161 – Tables

47 – Figures

296 – Pages

Key Player

The major players operating in this market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), GE Healthcare (US), Luminex Corporation (US), PerkinElmer Inc. (US), Waters Corporation (US), Illumina, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN Bioinformatics (Netherlands), Creative Proteomics (US), Promega Corporation (US), Sengenics (Singapore), Biomax Informatics AG (Germany), MS Bioworks LLC (US), WuXi NextCODE (China), Fios Genomics Ltd. (UK), GENEWIZ (US), Biognosys AG (Switzerland), Bioproximity (Switzerland), MRM Proteomics Inc. (Canada), Integrated Proteomics Applications (US), Poochon Scientific, LLC (US), Proteome Factory AG (Germany), VProteomics (India), HORIBA, Ltd. (Japan), and Applied Biomics, Inc. (US).

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=731

Merck KGaA (US) is a leading player across all the regions in proteomics market. Merck offers a wide range of proteomics solutions and services, such as assays, reagents, protein sample preparation services, detection and quantification kits, and other instruments through its Life Sciences business segment. The company operates in the US, Europe, the Asia Pacific, the Middle East, and Africa. Some of its major subsidiaries are Merck Millipore (US), EMD Pharmaceuticals Inc. (US), and Sigma-Aldrich Corporation (US). The company adopted expansion as a key strategy to strengthen its position globally and expand its product portfolio. For instance, in 2018, the company opened a new 3,800-square-meter laboratory in Singapore. This SGD bio-testing lab is the first of its kind outside of the US and the UK.

Danaher Corporation (US) is one of the leading players operating in the proteomics maket. The company has a strong product portfolio and a global presence in the diagnostics market. Danaher has adopted organic and inorganic growth strategies, such as product launches and partnerships, to strengthen its position in this market. For instance, in 2018, company launched BioPharmaView Software 3.0 and OptiFlow Quant Solution.

Clinical Diagnostics segment to register the largest share during the forecast period

Based on applications, the proteomics market is segmented into drug discovery, clinical diagnostics, and other applications. In 2020, the clinical diagnostics segment accounted for the largest share of the proteomics market. This can be attributed to the increased understanding of the relevance of investigating and understanding patterns of protein expression for disease diagnostics and drug development.

North America is the largest regional market for proteomics market

The global proteomics market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2020, North America accounted for the largest market share. This can be attributed to the increasing investments in the development of structure-based drug design, growing research in the field of omics, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics. The presence of a large number of global players in this region is also supporting the growth of this market.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=731

 About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html